This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by WAGNER, G. S. Articles by WALLACE, A. G. Search for Related Content PubMed PubMed Citation Articles by WAGNER, G. S. Articles by WALLACE, A. G.

(Circulation. 1973;47:263.)
© 1973 American Heart Association, Inc.

---

The Importance of Identification of the Myocardial-Specific Isoenzyme of Creatine Phosphokinase (MB Form) in the Diagnosis of Acute Myocardial Infarction

GALEN S. WAGNER M.D.¹; CHARLES R. ROE M.D.¹; LEE E. LIMBIRD ¹; ROBERT A. ROSATI M.D.¹; ANDREW G. WALLACE M.D.¹

¹ From the Departments of Medicine and Pediatrics, Duke University Medical Center, Durham, North Carolina.

Serial plasma determinations of the isoenzymes of CPK were performed in all patients (376) admitted to a coronary care unit during a 12-month period with diagnosis of possible acute myocardial infarction. Results were compared with data from other enzyme studies and from the electrocardiogram. An attempt was made to determine the incidence of falsely positive CPK-MB (myocardial-specific form). "No acute infarction" was diagnosed in all patients in whom neither total CPK nor the isoenzymes of LDH indicated myocardial necrosis, and in whom there were no QRS changes on ECG. Incidence of falsely negative CPK isoenzyme data was also determined. All patients, in whom total CPK was transiently elevated, and LDH₁ exceeded LDH₂, and new QRS changes occurred, were termed "definite" acute infarction. CPK-MB form was present in all 55 of these (0% false negative). Therefore, determination of the isoenzymes of CPK by this method provides both a sensitive and specific indication of acute myocardial infarction.

Key Words: Acute myocardial infarction • Enzymology • Isoenzymes • Creatine phosphokinase: MB form

Submitted on July 10, 1972
Accepted on October 10, 1972

This article has been cited by other articles:

				M. S. Sabatine, D. A. Morrow, L. J. Higgins, C. MacGillivray, W. Guo, C. Bode, N. Rifai, C. P. Cannon, R. E. Gerszten, and R. T. Lee Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial Infarction Circulation, April 15, 2008; 117(15): 1936 - 1944. [Abstract] [Full Text] [PDF]

				T. H. Lee, M. C. Weisberg, E. F. Cook, K. Daley, D. A. Brand, and L. Goldman Evaluation of Creatine Kinase and Creatine Kinase--MB for Diagnosing Myocardial Infarction: Clinical Impact in the Emergency Room Arch Intern Med, January 1, 1987; 147(1): 115 - 121. [Abstract] [PDF]

				T. H. LEE and L. GOLDMAN Serum Enzyme Assays in the Diagnosis of Acute Myocardial InfarctionRecommendations Based on a Quantitative Analysis Ann Intern Med, August 1, 1986; 105(2): 221 - 233. [Abstract] [PDF]

				J. W. McBride, K. R. Labrosse, H. G. McCoy, D. H. Ahrenholz, L. D. Solem, and I. F. Goldenberg Is Serum Creatine Kinase-MB in Electrically Injured Patients Predictive of Myocardial Injury? JAMA, February 14, 1986; 255(6): 764 - 768. [Abstract] [PDF]

				W. M. Tierney, J. Fitzgerald, R. McHenry, B. J. Roth, B. Psaty, D. L. Stump, and F. K. Anderson Physicians' Estimates of the Probability of Myocardial Infarction in Emergency Boom Patients with chest Pain Med Decis Making, February 1, 1986; 6(1): 12 - 17. [Abstract] [PDF]

				R. E. RUDE, J. E. MULLER, and B. EUGENE Efforts to Limit the Size of Myocardial Infarcts Ann Intern Med, December 1, 1981; 95(6): 736 - 761. [Abstract] [PDF]

				G. S. Wagner Optimal Use of Serum Enzyme Levels in the Diagnosis of Acute Myocardial Infarction: The Perspective in 1980 Arch Intern Med, March 1, 1980; 140(3): 317 - 319. [Abstract] [PDF]

				R. G. Irvin, F. R. Cobb, and C. R. Roe Acute Myocardial Infarction and MB Creatine Phosphokinase: Relationship Between Onset of Symptoms of Infarction and Appearance and Disappearance of Enzyme Arch Intern Med, March 1, 1980; 140(3): 329 - 334. [Abstract] [PDF]

				H. D. Strauss and R. Roberts Plasma MB Creatine Kinase Activity and Other Conventional Enzymes: Comparison in Patients With Chest Pain and Tachyarrhythmias Arch Intern Med, March 1, 1980; 140(3): 336 - 339. [Abstract] [PDF]

				A. Ahlbom and R. Nordlander Application of Diagnostic Criteria in the Diagnosis of Myocardial Infarction Scand J Public Health, January 1, 1979; 7(2): 67 - 72. [Abstract] [PDF]

				H. N. Neufeld, B. Rabinowitz, S. Clejan, and J. Doman Isoenzymes of Creatine Phosphokinase in Acute Myocardial Infarction Angiology, December 1, 1977; 28(12): 853 - 864. [PDF]

				R. S. Galen, J. A. Reiffel, and S. R. Gambino Diagnosis of Acute Myocardial Infarction: Relative Efficiency of Serum Enzyme and Isoenzyme Measurements JAMA, April 14, 1975; 232(2): 145 - 147. [Abstract] [PDF]

				K. Brownlow and F. R. Elevitch Serum Creatine Phosphokinase Isoenzyme (CPK2) in Myositis: A Report of Six Cases JAMA, November 25, 1974; 230(8): 1141 - 1144. [Abstract] [PDF]

				R. ROBERTS and B. E. SOBEL Isoenzymes of Creatine Phosphokinase and Diagnosis of Myocardial Infarction Ann Intern Med, November 1, 1973; 79(5): 741 - 743. [Abstract] [PDF]